The objective of this study is to obtain real-world evidence (RWE) on the safety and effectiveness of the plant-based medicine, ibogaine, as an addiction treatment. In collaboration with researchers from Nova Southeastern University, we are developing an online survey tool to capture RWE from volunteer respondents on their use of ibogaine as an addiction therapy to advance an FDA ibogaine drug development program. The registry is designed to generate the critical scientific assessments and patient-reported outcomes needed to optimize physician and patient use of ibogaine. Furthermore, it will be used to assess changes in the offshore use of ibogaine as an addiction treatment option as opioid use disorder management approaches evolve toward more access to medication-assisted treatment (MAT) in the US.